There is now so much information out there from so many independent and unbiased sources.. Avacta have a BAMS test, that will differentiate and give unique insight on individual patient treatment for COVID when positive... The Point of Care test that is being supported in development by U.K. GOV and FDA / US GOV will be a complete game changer in identifying , treating and tracking CVID positive people within minutes with no laboratory ... then include ACE2 immunotherapy in helping people across the globe and assisting in the prevention of contracting CVID 19 and probably any CVID related strain... why an amazing business and a phenomenally talented team!!
Why wait 9 years for you first post. This company have had more events that have made me sit up than this snippet of information that you highlight. The share consolidation for example & the price decline there after...